A detailed history of Gamma Investing LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Gamma Investing LLC holds 28,025 shares of ABT stock, worth $3.2 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
28,025
Previous 22,409 25.06%
Holding current value
$3.2 Million
Previous $2.33 Billion 37.22%
% of portfolio
0.32%
Previous 0.32%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$100.07 - $118.13 $561,993 - $663,418
5,616 Added 25.06%
28,025 $3.2 Billion
Q2 2024

Jul 02, 2024

BUY
$100.73 - $112.44 $380,155 - $424,348
3,774 Added 20.25%
22,409 $2.33 Billion
Q1 2024

Apr 05, 2024

BUY
$109.52 - $120.96 $186,184 - $205,632
1,700 Added 10.04%
18,635 $2.12 Billion
Q4 2023

Feb 01, 2024

BUY
$90.19 - $110.4 $1.53 Million - $1.87 Million
16,935 New
16,935 $1.92 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.